» Articles » PMID: 16472822

Mutational Analysis of the Catalytic Domain of the Murine Dnmt3a DNA-(cytosine C5)-methyltransferase

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2006 Feb 14
PMID 16472822
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

On the basis of amino acid sequence alignments and structural data of related enzymes, we have performed a mutational analysis of 14 amino acid residues in the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase. The target residues are located within the ten conserved amino acid sequence motifs characteristic for cytosine-C5 methyltransferases and in the putative DNA recognition domain of the enzyme (TRD). Mutant proteins were purified and tested for their catalytic properties and their abilities to bind DNA and AdoMet. We prepared a structural model of Dnmt3a to interpret our results. We demonstrate that Phe50 (motif I) and Glu74 (motif II) are important for AdoMet binding and catalysis. D96A (motif III) showed reduced AdoMet binding but increased activity under conditions of saturation with S-adenosyl-L-methionine (AdoMet), indicating that the contact of Asp96 to AdoMet is not required for catalysis. R130A (following motif IV), R241A and R246A (in the TRD), R292A, and R297A (both located in front of motif X) showed reduced DNA binding. R130A displayed a strong reduction in catalytic activity and a complete change in flanking sequence preferences, indicating that Arg130 has an important role in the DNA interaction of Dnmt3a. R292A also displayed reduced activity and changes in the flanking sequence preferences, indicating a potential role in DNA contacts farther away from the CG target site. N167A (motif VI) and R202A (motif VIII) have normal AdoMet and DNA binding but reduced catalytic activity. While Asn167 might contribute to the positioning of residues from motif VI, according to structural data Arg202 has a role in catalysis of cytosine-C5 methyltransferases. The R295A variant was catalytically inactive most likely because of destabilization of the hinge sub-domain of the protein.

Citing Articles

Characterization of Rationally Designed CRISPR/Cas9-Based DNA Methyltransferases with Distinct Methyltransferase and Gene Silencing Activities in Human Cell Lines and Primary Human T Cells.

Guerra-Resendez R, Lydon S, Ma A, Bedford G, Reed D, Kim S ACS Synth Biol. 2025; 14(2):384-397.

PMID: 39898483 PMC: 11854388. DOI: 10.1021/acssynbio.4c00569.


DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells.

Ramabadran R, Wang J, Reyes J, Guzman A, Gupta S, Rosas C Nat Cell Biol. 2023; 25(4):528-539.

PMID: 37024683 PMC: 10337578. DOI: 10.1038/s41556-023-01109-9.


Enzymology of Mammalian DNA Methyltransferases.

Jurkowska R, Jeltsch A Adv Exp Med Biol. 2022; 1389:69-110.

PMID: 36350507 DOI: 10.1007/978-3-031-11454-0_4.


Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stability.

de Mendoza A, Nguyen T, Ford E, Poppe D, Buckberry S, Pflueger J Genome Biol. 2022; 23(1):163.

PMID: 35883107 PMC: 9316731. DOI: 10.1186/s13059-022-02728-5.


Understanding the R882H mutation effects of DNA methyltransferase DNMT3A: a combination of molecular dynamics simulations and QM/MM calculations.

Liu L, Shi T, Houk K, Zhao Y RSC Adv. 2022; 9(54):31425-31434.

PMID: 35527972 PMC: 9072302. DOI: 10.1039/c9ra06791d.